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Abstract
Background: Inadequate bowel movement is a common problem in intensive care patients. Aim of this study
was to quantify the frequency of disturbed defecation pattern in critical ill neurosurgical patients and examine the
influence on intracranial pressure (ICP) and treatment on intensive care unit (ICU).
Patients and Methods: Data were collected retrospectively during treatment on a neurosurgical ICU over a
period of three years. Daily bowel movement was regarded to be sufficient when stool volume was more than 150 ml
liquid or mushy stool or the patient produced enough formed stool. Patients were classified into group “adequate
defecation” when no period of more than three consecutive days without sufficient bowel movement was seen during
ICU treatment or into group “inadequate defecation” respectively. A third group was built with patients showing
constipation on seven consecutive days or longer.
Results: In a total of 73 recorded patients, 11 showed an adequate defecation pattern. Within the first ten days of
ICU stay mean daily ICP values did not differ. However, patients with inadequate defecation had to be ventilated
mechanically significantly longer (15.9 vs. 8.8 days) and had a significant longer need for ICU treatment (24.8 vs.
15.6 days). The mean cumulative dose of sedatives, sufentanil and norepinephrine was significantly higher in
patients showing inadequate defecation. However, even long periods of constipation were not associated with a
clinically relevant increase of ICP.
Conclusion: Neurosurgical ICU patients often show constipation. This does not cause elevated ICP values
compared to patients without constipation. Disturbed bowel movement is associated with higher dosage of
analgosedation and vasopressor therapy. Patients without constipation have to be ventilated less long and can be
discharged from ICU earlier.
Keywords: Bowel movement; Defecation; Constipation; Intracranial
pressure; Neurosurgical intensive care
Introduction
Motility disorders and disturbed defecation pattern seem to have
impact on the development of increased ICP in patients with brain
injury. Various reasons as e.g., prolonged periods of analgosedation, as
often necessary after traumatic brain injury (TBI) or subarachnoid
hemorrhage (SAH) may lead to insufficient bowel movement and even
a state resembling paralytic ileus. This can result in an increase in
intra-abdominal pressure (IAP) and potentially an increased
intracranial pressure (ICP) [1-3]. In addition, an insufficient defecation
rate is possibly associated with prolonged ventilation, increased rate of
bacterial infection and a higher mortality rate [4-10].
Recently we could show that the implementation of a standard
operating procedure (SOP) for treatment of constipation on a ICU
increased the stool frequency but had no impact on ICP [11]. The aim
of the following study was therefore to evaluate the effects of bowel
movements per se on ICP and length of respirator dependency or ICU
stay in patients with an acute serious cerebral disorder.
Patients and Methods
The study was approved and conducted according to the ethical care
committee of the University of Regensburg (approval number
12-101-0240).
Criteria for being included into this study were an age older than 18
years, a severe brain injury such as TBI, SAH, intracerebral
hemorrhage (ICH) or other serious cerebral disorders and the
necessity of continuous ICP monitoring, continuous analgosedation
and invasive ventilation for more than three days. Exclusion criteria
were pregnancy and severe gastro-intestinal diseases. Data from all
patients who had met these criteria and had been treated on the
neurosurgical ICU of the University Hospital Regensburg within a
period of three years between January 2011 and December 2013 were
collected retrospectively.
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For each day of ICU treatment the following data were extracted
from the patient data management system (PDMS, MetaVision
SuiteTM, iMDsoft, Tel Aviv, Israel): gut motility parameters, dose of
drugs for analgosedation and circulatory-support (mean total dose
during ICU treatment), ICP-levels (mean daily values), duration of
mechanical ventilation and length of ICU stay.
Nutritional support was given according to the guidelines of the
German Society for Nutrition (DGEM 2007, www.dgem.de) and the
European Society for Clinical Nutrition and Metabolism (ESPEN 2005;
www.espen.org). To improve defecation pattern physical therapy and
pro motility drugs (mainly bisacodyl, lactulose, clyster, enteral given
naloxone, sodium picosulfate, rhizine oil and neostigmine) were given
following clinical assessment and the attending physician´s estimation.
The defecation pattern was recorded separately for each day of ICU
stay (0.00 am to 11.59 pm). Stool volume was measured using a fecal
collector (FlexiSeal TM, ConvaTec, Munich, Germany) when patients
had liquid or soft, mushy stool. In patients who had formed stool the
classification in being enough or too few for a day was done
corresponding to the assessment by the attending nurse. A cumulative
stool volume of more than 150 ml per day or enough formed stool for a
day as documented in the PDMS was regarded to be a sufficient
defecation. According to this, patients were initially divided into two
groups: patients who had not shown a period of more than three
consecutive days without sufficient bowel movement were classified
into group “adequate defecation”, patients with periods of more than
three consecutive days with constipation into group “inadequate
defecation”. In addition, patients with episodes of insufficient bowel
movement on at least seven consecutive days were classified into group
“long period with inadequate defecation” and recorded separately.
Statistical analysis was performed using IBM SPSS Statistics TM
Version 22 (IBM, Armonk, USA). Categorical data were displayed
according to the distribution frequency. Statistical significance was
calculated using chi-square test. Metric data were analyzed using
Student´s t-test when data were normally distributed or Mann-
Whitney U test when not. Significance was supposed when p-value was
<0.05. As not otherwise indicated data are presented as mean ±
standard deviation.
Results
A total of 73 patients (29 female, 44 male, average age 48.2 years, ±
16.9 years) met inclusion criteria and were enrolled. 28 patients
(38.3%, 20 female, 8 male) suffered from SAH, 25 patients (34.3%, 3
female, 22 male) from TBI, 13 patients (17.8%, 4 female, 9 male) from
other types of ICH and finally 7 patients (9.6%, 2 female, 5 male) from
cerebral ischemia.
11 patients (15.1%) showed adequate defecation according to the
definition given above (group “adequate defecation”). 4 patients in this
group were female (13.8% of all female patients), 7 male (15.9% of all
male patients). 62 patients (84.9%) were assigned to group “inadequate
defecation”. A period of insufficient bowel movement on at least seven
consecutive days (group “long period with inadequate defecation”) was
detected in 28 patients (46.8% of the patients of group “inadequate
defecation, 38.4% of all patients respectively). 8 patients in this group
were female (27.6% of all female patients), 20 male (45.5% of all male
patients).
Defecation and ICP
The initially established ICP probe was removed as soon as possible
after reaching a stable situation regarding ICP values to prevent
infectious complications. Therefore, a continuous recording of ICP
values during the first ten days of ICU stay was available in only 56
patients. During this period, inadequate defecation for more than three
consecutive days occurred in 49 of these patients. 7 patients showed a
normal defecation pattern. Within the patients with inadequate
defecation pattern two patients showed extremely elevated mean daily
ICP values on day 9 (56.31 mmHg and 36.46 mmHg) and 10 (106.84
mmHg and 85.07 mmHg) due to multiple infarction as a consequence
of severe cerebral vasospasm following SAH and an intracerebral
bleeding after installing an external ventricular drainage respectively
with deleterious prognosis. Therefore, both patients were excluded
from the calculations. Table 1 shows the development of the mean
daily ICP value over the time comparing both groups. A significant
difference of mean daily ICP values was not seen throughout the whole
observation period.
 Mean Group
“Inadequate
defecation”
(mmHg)
Mean Group
“Adequate
defecation”
(mmHg)
MD
(mmHg)
95%-CI p-value
Day 1 10.43 8.35 2.08 -2.67; 6.84 0.327
Day 2 11.73 12.47 -0.74 -3.77; 2.29 0.598
Day 3 11.63 11.92 -0.29 -3.02; 2.44 0.815
Day 4 10.86 11.44 -0.58 -3.91; 2.73 0.694
Day 5 11.10 11.02 0.08 -2.98; 3.14 0.954
Day 6 11.43 11.02 0.41 -1.56; 2.37 0.663
Day 7 10.95 10.66 0.29 -1.72; 2.30 0.760
Day 8 11.68 10.50 1.18 -0.76; 3.11 0.212
Day 9 11.08 10.56 0.52 -1.87; 2.90 0.644
Day 10 11.32 9.29 2.03 -0.50; 4.56 0.109
Table 1: Mean daily ICP values until day 10 after admission to the ICU.
MD: Mean Difference; CI: Confidence Interval.
Defecation and ICU therapy
Patients classified into group “adequate defecation” had to be
ventilated mechanically for an average of 8.8 days, whereas
“inadequate defecation” group patients were ventilator-dependent for
15.9 days. This was a statistically significant mean difference of 7.1
days (95%-CI 4.4; 9.7). The shortest ventilation period was 5 days in
group “adequate defecation” and 3 days in group “inadequate
defecation”, the longest period 13 days vs. 42 days respectively. The
mean length of ICU stay was 16.5 days in group “adequate defecation”
and 24.8 days in group “inadequate defecation”. This was also a
statistically significant mean difference of 8.4 days (95%-CI 4.7; 12.0).
Defecation and analgosedation
Propofol, midazolam, ketamine and if necessary methohexital on
top were given for sedation and sufentanil was used for analgesia. The
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mean cumulative dose was significantly higher in the group
“inadequate defecation” for all drugs (Table 2).
Cumulative
dose Group
“inadequate
defecation”
(g)
Cumulative
dose Group
“adequate
defecation”
(g)
MD (g) 95% CI p-value
Propofol 24.06 12.91 11.15 2.59; 19.73 0.012
Midazolam 3.81 1.12 2.69 1.48; 3.89 <0.001
Ketamine 30.26 7.72 22.54 10.68;34.40
<0.001
Methohexita
l
4.98 0 4.98 2.15; 7.82 0.001
Sufentanil 0.020 0.008 0.012 0.007;0.017
<0.001
Table 2: Cumulative dose of drugs used for analgosedation. MD: Mean
Difference; CI: Confidence Interval.
Defecation and circulatory support
For circulatory support norepinephrine, dobutamine or epinephrine
were given if necessary. The mean cumulative dose was significantly
higher in group “inadequate defecation” for norepinephrine but not for
dobutamine or epinephrine despite a tendency towards higher doses
for both agents in this group (Table 3).
Long period of obstipation and ICP
A noticeable number of 28 patients showed at least once an episode
of insufficient bowel movement for at least seven consecutive days
(group “long period with inadequate defecation”).
 Group
“inadequate
defecation”
Cumulative
dose (mg)
Group
“adequate
defecation”
Cumulative
dose (mg)
MD
(mg)
 
95% CI p-value
Norepinephrine 192.2 106.2 86.0 13.7; 158.3 0.021
Dobutamine 105.8 72.7 33.1 -104.1;
170.5
0.615
Epinephrine 10.4 0.2 10.2 5.3; -0.4 0.058
Table 3: Cumulative dose of catecholamines. MD: Mean Difference; CI:
Confidence Interval.
 Patient number Mean daily ICP (mmHg)
Day 1 2 3 4 5 6 7 8 9 10 11 12 13
3 12.4 15.4 15.7 14.1 13.2 13.8 12.4 12.1
6 3.7 6.8 7.5 7.1 9.9 7.2 7.6
9 11.6 9.9 9.1 10.3 10.9 12.9 13.1 16.1 24.6
25 12.8 12.1 10.4 10.9 11.9 11.0 12.5
26 8.6 17.1 17.1 20.4 16.9 17.3 15.6 17.7
27 1.0 7.0 7.7 6.3 5.0 2.9 3.1
35 14.0 13.6 11.6 9.4 9.8 11.4 11.3 12.1 11.4 12.5 10.5 11.3 10.1
37 18.4 16.1 17.0 17.0 15.8 15.1 18.5 15.1
39 11.4 8.4 11.0 11.0 9.2 8.9 9.9 11.6
40 18.6 16.2 13.0 12.0 12.6 12.6 11.9 12.2 10.1 13.2
42 29.0 10.8 13.5 14.7 16.3 14.9 13.6 14.8 20.9
46 20.1 21.1 23.8 24.2 25.4 24.4 23.1
51 16.0 19.4 15.0 8.9 7.3 6.0 9.0 12.6 8.2 9.9 4.5 5.3 5.2
53 11.5 14.9 13.9 14.1 14.5 16.1 17.3 22.3 20.8 17.8
59 3.9 5.0 7.1 10.2 12.4 9.3 6.3 7.8 6.0
70 9.6 9.6 9.0 5.0 6.6 6.6 9.5
73 3.1 5.5 8.8 6.1 7.6 15.6 14.0       
Table 4: Mean daily ICP in patients with a long period without adequate defecation. Day 1 is the first day of this period starting one day after last
sufficient defecation.
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A continuous recording of the ICP values during these episodes
existed in 19 patients out of this group. Again two patients were
excluded due to deleterious prognosis. Thus 17 patients remained in
which the development of the mean daily ICP values during this long
period without adequate defecation could be compared (Table 4). We
only saw a slight increase of 1.07 mmHg (12.10 mmHg, ± 7.13 mmHg
on day 1 vs. 13.17 mmHg, ± 6.18 mmHg on the last day) in mean daily
ICP. Two patients (number 35 and 51) had a remarkably long period of
13 consecutive days without adequate defecation. In these two patients
the mean daily ICP even declined and was lower on the last day of this
episode than at the beginning.
Discussion
The present study shows that an insufficient defecation pattern is a
common problem in critically ill neurosurgical patients as only 15.1%
of all patients showed adequate defecation at least every third day
during the observation period. Interestingly even longer periods
without adequate defecation were not associated with elevated mean
daily ICP values compared to patients showing an adequate defecation
pattern. However, patients with regular bowel movement had to be
ventilated and treated significantly shorter on ICU.
In literature the incidence of constipation varies from 16% to 84% in
critically ill patients [8-10,12-15]. Main reasons for this variance might
be the inhomogeneity of the study populations and the lack of a
general definition of regular bowel movement. We recently examined
the defecation pattern within the first 5 days after ICU admission in
neurosurgical intensive care patients comparing a group where
laxatives and physical measures had been applicated in a standardized
manner after implementation of a SOP to a group where the pro
motility measures had been ordered without any schedule merely
according to the attending physician’s estimation. In this study the
number of patients showing adequate defecation was over all low with
24% in the intervention group and 8.3% in the control group
respectively [11]. In concordance to these previous findings the
percentage of patients with regular defecation was 15.1% in the present
study.
It might be assumed that the absence of defecation leads to elevated
IAP levels over time. The association between an elevated IAP and
rising ICP values has been described repeatedly [1-3, 16-19]. However,
it is difficult to predict the development of IAP in the individual
critically ill patient [20-23]. In our previous study we had not seen
higher ICP levels in the group showing an inadequate defecation
pattern. However, in the preceding study we only observed the first five
days after admission to the ICU. We supposed that this short period of
time was not long enough to find a detectable effect of inadequate
defecation pattern on the ICP levels as probably this period was too
short to develop a relevant increase in IAP due to lack of defecation.
This was the main reason for initiating the present study, now
examining the whole time of intensive care treatment. Although the
initially established ICP probes were removed as soon as possible in
order to prevent infectious complications we were able to analyze data
of 56 patients who had a continuous ICP measurement during the first
ten days of ICU stay. Once again no difference was seen between the
mean ICP values in the patients showing an adequate defecation
pattern compared to those whose bowel movement was insufficient.
Even in patients with a remarkably long period of at least seven
consecutive days without adequate defecation no relevant increase of
ICP was detected. These findings seem to be surprising, but probably
only a manifest abdominal compartment syndrome can induce a
relevant ICP elevation as several case reports and a small patient series
suggest. Unfortunately, the IAP values were not recorded regularly in
the study population what in fact is a limitation of our present study.
Therefore, it is impossible to rule out that even in cases with an
extremely long period without defecation an increase in ICP was not
seen simply because there was no relevant elevation in IAP.
However, another result of the current study may provide a different
interpretation approach. The mean cumulative dose of all sedatives
and sufentanil was significantly higher in the group “inadequate
defecation”. Correspondingly norepinephrine that was used as first line
vasopressor also had to be given in higher dosage when defecation
pattern was inadequate. These findings are in concordance to literature
where an association between sedatives, analgesics (especially opioids)
and vasopressors and constipation is described [5,7,24-26]. All these
drugs are well-known to impair gut motility in a dose-dependent
manner. Therefore, the higher dosage of the applied drugs might be the
reason for the disturbed defecation pattern. On the other hand,
however, the situation could be interpreted inversely as well so that a
deeper analgosedation could have been necessary to control borderline
ICP levels in patients with inadequate defecation pattern. Deep
analgosedation is an elementary aspect of conservative treatment of
elevated ICP. Thus higher dosages of vasopressors could have been
necessary due to deeper analgosedation. The observed prolonged
ventilator dependency and duration of ICU therapy in patients with
disturbed bowel movements seems also to be in line with this
interpretation. In this context prolonged respirator therapy could have
been necessary because of longer and deeper analgosedation.
Furthermore, the weaning phase from the respirator is often associated
with a moderate hypercapnia. It is likely that a reduction of the
respirator therapy invasivity allowing spontaneous breathing was not
possible in those patients with inadequate defecation pattern as the
resulting moderate hypercapnia would have led to an excess of ICP
thresholds.
In summary, the present study can lead to different interpretation
approaches and is not able to draw a chain of causation free of doubt.
Seen from a pure clinical standpoint efforts for optimizing bowel
movements in critically ill patients with acute severe cerebral disorders
seem to be justified as we have seen a correlation between an
insufficient defecation pattern and a longer duration of ventilator
dependency and ICU treatment. To be able to answer the open
questions we are in need of larger prospective studies with regular
measurement of IAP and inclusion of protocol-based strategies for
optimizing bowel movement and defecation in critically ill
neurosurgical patients.
Conclusion
Critically ill patients with an acute severe cerebral disorder often
show an inadequate defecation pattern. This, however, seems not to be
associated with elevated ICP levels even if patients do not show an
adequate bowel movement for seven consecutive days or even longer.
On the other hand, higher doses of drugs for analgosedation and
circulatory support are necessary in these patients. In addition,
compared to patients with an adequate defecation pattern those
patients show a prolonged ventilator dependency and are in need of a
longer ICU treatment.
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